Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Skiest, DJ
   Focal neurological disease in patients with acquired immunodeficiency syndrome
   CLINICAL INFECTIOUS DISEASES
   
   D.J. Skiest, "Focal neurological disease in patients with acquired immunodeficiency syndrome", CLIN INF D, 34(1), 2002, pp. 103-115
2. Aldape, K; Ginzinger, DG; Godfrey, TE
   Real-time quantitative polymerase chain reaction: A potential tool for genetic analysis in neuropathology
   BRAIN PATHOLOGY
   
   K. Aldape et al., "Real-time quantitative polymerase chain reaction: A potential tool for genetic analysis in neuropathology", BRAIN PATH, 12(1), 2002, pp. 54-66
3. Devereux, HL; Burke, A; Lee, CA; Johnson, MA
   In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution
   JOURNAL OF MEDICAL VIROLOGY
   
   H.L. Devereux et al., "In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution", J MED VIROL, 66(1), 2002, pp. 8-12
4. Ghosal, N; Kapila, K; Kakkar, S; Verma, K
   Langerhans cell histiocytosis infiltration in cerebrospinal fluid: A case report
   DIAGNOSTIC CYTOPATHOLOGY
   
   N. Ghosal et al., "Langerhans cell histiocytosis infiltration in cerebrospinal fluid: A case report", DIAGN CYTOP, 24(2), 2001, pp. 123-125
5. Nalivaeva, NN; Turner, AJ
   Post-translational modifications of proteins: Acetylcholinesterase as a model system
   PROTEOMICS
   
   N.N. Nalivaeva e A.J. Turner, "Post-translational modifications of proteins: Acetylcholinesterase as a model system", PROTEOMICS, 1(6), 2001, pp. 735-747
6. Davidsson, P; Paulson, L; Hesse, C; Blennow, K; Nilsson, CL
   Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electophoresis approach prior to mass spectrometry
   PROTEOMICS
   
   P. Davidsson et al., "Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electophoresis approach prior to mass spectrometry", PROTEOMICS, 1(3), 2001, pp. 444-452
7. Salmaggi, A; Maccagnano, E; Castagna, A; Zeni, S; Fantini, F; Cinque, P; Savoiardo, M
   Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy
   NEUROLOGICAL SCIENCES
   
   A. Salmaggi et al., "Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy", NEUROL SCI, 22(1), 2001, pp. 17-20
8. Ossege, LM; Sindern, E; Patzold, T; Malin, JP
   Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   L.M. Ossege et al., "Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis", INT IMMUNO, 1(6), 2001, pp. 1085-1100
9. Upton, RN; Ludbrook, GL; Grant, C; Martinez, A
   In vivo cerebral pharmacokinetics and pharmacodynamics of diazepam and midazolam after short intravenous infusion administration in sheep
   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
   
   R.N. Upton et al., "In vivo cerebral pharmacokinetics and pharmacodynamics of diazepam and midazolam after short intravenous infusion administration in sheep", J PHARMA PH, 28(2), 2001, pp. 129-153
10. Higley, JD
    Individual differences in alcohol-induced aggression - A nonhuman-primate model
    ALCOHOL RESEARCH & HEALTH
    
    J.D. Higley, "Individual differences in alcohol-induced aggression - A nonhuman-primate model", ALCOHOL R H, 25(1), 2001, pp. 12-19
11. Slattery, WH; Francis, S; House, KC
    Perioperative morbidity of acoustic neuroma surgery
    OTOLOGY & NEUROTOLOGY
    
    W.H. Slattery et al., "Perioperative morbidity of acoustic neuroma surgery", OTOL NEURO, 22(6), 2001, pp. 895-902
12. Leonetti, JP; Anderson, D; Marzo, S; Moynihan, G
    Prevention and management of cerebrospinal fluid fistula after transtemporal skull base surgery
    SKULL BASE-AN INTERDISCIPLINARY APPROACH
    
    J.P. Leonetti et al., "Prevention and management of cerebrospinal fluid fistula after transtemporal skull base surgery", SKULL BASE, 11(2), 2001, pp. 87-92
13. Das, K; Murali, R; Lindstrom, CJ; Couldwell, WT
    Symptomatic subdural hygroma and temporal lobe edema after translabyrinthine removal of acoustic neuroma
    SKULL BASE-AN INTERDISCIPLINARY APPROACH
    
    K. Das et al., "Symptomatic subdural hygroma and temporal lobe edema after translabyrinthine removal of acoustic neuroma", SKULL BASE, 11(2), 2001, pp. 137-142
14. Schmerber, S; Righini, C; Lavielle, JP; Passagia, JG; Reyt, E
    Endonasal endoscopic closure of cerebrospinal fluid rhinorrhea
    SKULL BASE-AN INTERDISCIPLINARY APPROACH
    
    S. Schmerber et al., "Endonasal endoscopic closure of cerebrospinal fluid rhinorrhea", SKULL BASE, 11(1), 2001, pp. 47-58
15. Howell, SB
    Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam (TM) technology
    CANCER JOURNAL
    
    S.B. Howell, "Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam (TM) technology", CANCER J, 7(3), 2001, pp. 219-227
16. Strauss, GI; Christiansen, M; Moller, K; Clemmesen, JO; Larsen, FS; Knudsen, GM
    S-100b and neuron-specific enolase in patients with fulminant hepatic failure
    LIVER TRANSPLANTATION
    
    G.I. Strauss et al., "S-100b and neuron-specific enolase in patients with fulminant hepatic failure", LIVER TRANS, 7(11), 2001, pp. 964-970
17. Solomon, B; Seymour, JE
    Commentary on "High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma"
    CLINICAL LYMPHOMA
    
    B. Solomon e J.E. Seymour, "Commentary on "High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma"", CLIN LYMPHO, 2(2), 2001, pp. 121-122
18. Coffey, RJ
    Deep brain stimulation for chronic pain: Results of two multicenter trialsand a structured review
    PAIN MEDICINE
    
    R.J. Coffey, "Deep brain stimulation for chronic pain: Results of two multicenter trialsand a structured review", PAIN MED, 2(3), 2001, pp. 183-192
19. Tozzi, V; Balestra, T; Galgani, S; Narciso, P; Sampaolesi, A; Antinori, A; Giulianelli, M; Serraino, I; Ippolito, G
    Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    V. Tozzi et al., "Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years", J ACQ IMM D, 28(1), 2001, pp. 19-27
20. Aung, H; McKenna, SM; Ketoff, NR; Jones, L; Wu, M; Hejal, R; Rich, EA; Toossi, Z
    Dysregulation of beta-chemokines in the lungs of HIV-1-infected patients
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    H. Aung et al., "Dysregulation of beta-chemokines in the lungs of HIV-1-infected patients", J ACQ IMM D, 26(4), 2001, pp. 305-314
21. Hecker, JG; Hall, LL; Irion, VR
    Nonviral gene delivery to the lateral ventricles in rat brain: Initial evidence for widespread distribution and expression in the central nervous system
    MOLECULAR THERAPY
    
    J.G. Hecker et al., "Nonviral gene delivery to the lateral ventricles in rat brain: Initial evidence for widespread distribution and expression in the central nervous system", MOL THER, 3(3), 2001, pp. 375-384
22. Qian, ZM; Shen, X
    Brain iron transport and neurodegeneration
    TRENDS IN MOLECULAR MEDICINE
    
    Z.M. Qian e X. Shen, "Brain iron transport and neurodegeneration", TRENDS MO M, 7(3), 2001, pp. 103-108
23. Clark, WM; Lutsep, HL
    Potential of anticytokine therapies in central nervous system ischaemia
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    W.M. Clark e H.L. Lutsep, "Potential of anticytokine therapies in central nervous system ischaemia", EXPERT OP B, 1(2), 2001, pp. 227-237
24. Tirucherai, GS; Yang, C; Mitra, AK
    Prodrugs in nasal drug delivery
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    G.S. Tirucherai et al., "Prodrugs in nasal drug delivery", EXPERT OP B, 1(1), 2001, pp. 49-66
25. Urushitani, M; Shimohama, S
    The role of nitric oxide in amyotrophic lateral sclerosis
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    
    M. Urushitani e S. Shimohama, "The role of nitric oxide in amyotrophic lateral sclerosis", AMYOTROPH L, 2(2), 2001, pp. 71-81
26. Bilak, MM; Corse, AM; Kuncl, RW
    Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    
    M.M. Bilak et al., "Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons", AMYOTROPH L, 2(2), 2001, pp. 83-91
27. Matta, B; Shankar, R
    Recent advances in neuroanaesthesia
    HOSPITAL MEDICINE
    
    B. Matta e R. Shankar, "Recent advances in neuroanaesthesia", HOSP MED, 62(8), 2001, pp. 480-486
28. Schotte, H; Schluter, B; Rust, S; Assmann, G; Domschke, W; Gaubitz, M
    Interleukin-6 promoter polymorphism (-174 GIG) in Caucasian German patients with systemic lupus erythematosus
    RHEUMATOLOGY
    
    H. Schotte et al., "Interleukin-6 promoter polymorphism (-174 GIG) in Caucasian German patients with systemic lupus erythematosus", RHEUMATOLOG, 40(4), 2001, pp. 393-400
29. Legangneux, E; Mora, JJ; Spreux-Varoquaux, O; Thorin, I; Herrou, M; Alvado, G; Gomeni, C
    Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [H-3]imipramine reuptake in the primary fibromyalgia syndrome
    RHEUMATOLOGY
    
    E. Legangneux et al., "Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [H-3]imipramine reuptake in the primary fibromyalgia syndrome", RHEUMATOLOG, 40(3), 2001, pp. 290-296
30. Rohlff, C
    Proteomics in neuropsychiatric disorders
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    
    C. Rohlff, "Proteomics in neuropsychiatric disorders", IN J NEUROP, 4(1), 2001, pp. 93-102
31. Ernst, S; Ernestus, RI; Kugel, H; Lackner, K
    MR imaging and CSF flow measurement before and after neuroendoscipic thirdventriculostomy.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    S. Ernst et al., "MR imaging and CSF flow measurement before and after neuroendoscipic thirdventriculostomy.", ROFO-F RONT, 173(6), 2001, pp. 502-508
32. Freund, M; Adwan, M; Kooijman, H; Heiland, S; Thomsen, M; Hahnel, S; Jensen, K; Gerner, HJ; Sartor, K
    Quantitative analysis of spinel CSF dynamics using magnetic resonance imaging: Experimental and clinical studies
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    M. Freund et al., "Quantitative analysis of spinel CSF dynamics using magnetic resonance imaging: Experimental and clinical studies", ROFO-F RONT, 173(4), 2001, pp. 306-314
33. Arand, M; Melzner, H; Kinzl, L; Bruckner, UB; Gebhard, F
    Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans
    LANGENBECKS ARCHIVES OF SURGERY
    
    M. Arand et al., "Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans", LANG ARCH S, 386(4), 2001, pp. 241-248
34. Reiber, H; Otto, M; Trendelenburg, C; Wormek, A
    Reporting cerebrospinal fluid data: Knowledge base and interpretation software
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    H. Reiber et al., "Reporting cerebrospinal fluid data: Knowledge base and interpretation software", CLIN CH L M, 39(4), 2001, pp. 324-332
35. Sindic, CJM; Van Antwerpen, MP; Goffette, S
    The intrathecal humoral immune response: Laboratory analysis and clinical relevance
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    C.J.M. Sindic et al., "The intrathecal humoral immune response: Laboratory analysis and clinical relevance", CLIN CH L M, 39(4), 2001, pp. 333-340
36. Bertsch, T; Kuehl, S; Muehlhauser, F; Walter, S; Hodapp, B; Rossol, S; Schmeck, J; Ragoschke, A; Schutt, S; Fritzinger, M; Horn, P; Vajkoczy, P; Wendel-Wellner, M; Fassbender, K
    Source of endothelin-1 in subarachnoid hemorrhage
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    T. Bertsch et al., "Source of endothelin-1 in subarachnoid hemorrhage", CLIN CH L M, 39(4), 2001, pp. 341-345
37. Soletormos, G; Bach, F
    Tissue polypeptide-specific antigen (TPS) concentrations in cerebrospinal fluid in patients with breast cancer metastases in the central nervous system
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    G. Soletormos e F. Bach, "Tissue polypeptide-specific antigen (TPS) concentrations in cerebrospinal fluid in patients with breast cancer metastases in the central nervous system", CLIN CH L M, 39(2), 2001, pp. 170-172
38. Albach, C; Klein, RA; Schmitz, B
    Do rodent and human brains have different N-glycosylation patterns?
    BIOLOGICAL CHEMISTRY
    
    C. Albach et al., "Do rodent and human brains have different N-glycosylation patterns?", BIOL CHEM, 382(2), 2001, pp. 187-194
39. Regland, B; Lehmann, W; Abedini, I; Blennow, K; Jonsson, M; Karlsson, I; Sjogren, M; Wallin, A; Xilinas, M; Gottfries, CG
    Treatment of Alzheimer's disease with clioquinol
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    B. Regland et al., "Treatment of Alzheimer's disease with clioquinol", DEMENT G C, 12(6), 2001, pp. 408-414
40. Tarkowski, E; Liljeroth, AM; Nilsson, A; Minthon, L; Blennow, K
    Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    E. Tarkowski et al., "Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease", DEMENT G C, 12(5), 2001, pp. 314-317
41. Davidsson, P; Bogdanovic, N; Lannfelt, L; Blennow, K
    Reduced expression of amyloid precursor protein, presenilin-1 and rab3a incortical brain regions in Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    P. Davidsson et al., "Reduced expression of amyloid precursor protein, presenilin-1 and rab3a incortical brain regions in Alzheimer's disease", DEMENT G C, 12(4), 2001, pp. 243-250
42. Sjogren, M; Davidsson, P; Gottfries, J; Vanderstichele, H; Edman, A; Vanmechelen, E; Wallin, A; Blennow, K
    The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    M. Sjogren et al., "The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process", DEMENT G C, 12(4), 2001, pp. 257-264
43. Yamagata, K; Urakami, K; Ikeda, K; Ji, Y; Adachi, Y; Arai, H; Sasaki, H; Sato, K; Nakashima, K
    High expression of apolipoprotein e mRNA in the brains with sporadic Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    K. Yamagata et al., "High expression of apolipoprotein e mRNA in the brains with sporadic Alzheimer's disease", DEMENT G C, 12(2), 2001, pp. 57-62
44. Blomberg, M; Jensen, M; Basun, H; Lannfelt, L; Wahlund, LO
    Cerebrospinal fluid tau levels increase with age in healthy individuals
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    M. Blomberg et al., "Cerebrospinal fluid tau levels increase with age in healthy individuals", DEMENT G C, 12(2), 2001, pp. 127-132
45. Soderstrom, M
    Optic neuritis and multiple sclerosis
    ACTA OPHTHALMOLOGICA SCANDINAVICA
    
    M. Soderstrom, "Optic neuritis and multiple sclerosis", ACT OPHTH S, 79(3), 2001, pp. 223-227
46. Rubino, FM
    Separation methods for methotrexate, its structural analogues and metabolites
    JOURNAL OF CHROMATOGRAPHY B
    
    F.M. Rubino, "Separation methods for methotrexate, its structural analogues and metabolites", J CHROMAT B, 764(1-2), 2001, pp. 217-254
47. Ba, BB; Saux, MC
    Separation methods for antiviral phosphorus-containing drugs
    JOURNAL OF CHROMATOGRAPHY B
    
    B.B. Ba e M.C. Saux, "Separation methods for antiviral phosphorus-containing drugs", J CHROMAT B, 764(1-2), 2001, pp. 349-362
48. Aarnoutse, RE; Wissen, CPWGMVV; Underberg, WJM; Kleinnijenhuis, J; Hekster, YA; Burger, DM
    High-performance liquid chromatography of HIV protease inhibitors in humanbiological matrices
    JOURNAL OF CHROMATOGRAPHY B
    
    R.E. Aarnoutse et al., "High-performance liquid chromatography of HIV protease inhibitors in humanbiological matrices", J CHROMAT B, 764(1-2), 2001, pp. 363-384
49. Syriopoulou, V; Brooks, JB; Daikos, GL
    Electron-capture gas chromatographic-chemical ionization mass spectrometric study of sera from people vaccinated with bacille Calmette-Guerin for characteristic metabolites
    JOURNAL OF CHROMATOGRAPHY B
    
    V. Syriopoulou et al., "Electron-capture gas chromatographic-chemical ionization mass spectrometric study of sera from people vaccinated with bacille Calmette-Guerin for characteristic metabolites", J CHROMAT B, 751(1), 2001, pp. 143-151
50. Ustacelebi, S
    Diagnosis of herpes simplex virus infections
    JOURNAL OF CLINICAL VIROLOGY
    
    S. Ustacelebi, "Diagnosis of herpes simplex virus infections", J CLIN VIRO, 21(3), 2001, pp. 255-259
51. Lipson, SM; Svenssen, L; Goodwin, L; Porti, D; Danzi, S; Pergolizzi, R
    Evaluation of two current generation enzyme immunoassays and an improved isolation-based assay for the rapid detection and isolation of rotavirus from stool
    JOURNAL OF CLINICAL VIROLOGY
    
    S.M. Lipson et al., "Evaluation of two current generation enzyme immunoassays and an improved isolation-based assay for the rapid detection and isolation of rotavirus from stool", J CLIN VIRO, 21(1), 2001, pp. 17-27
52. Henquell, C; Chambon, M; Bailly, JL; Alcaraz, S; De Champs, C; Archimbaud, C; Labbe, A; Charbonne, F; Peigue-Lafeuille, H
    Prospective analysis of 61 cases of enteroviral meningitis: interest of systematic genome detection in cerebrospinal fluid irrespective of cytologic examination results
    JOURNAL OF CLINICAL VIROLOGY
    
    C. Henquell et al., "Prospective analysis of 61 cases of enteroviral meningitis: interest of systematic genome detection in cerebrospinal fluid irrespective of cytologic examination results", J CLIN VIRO, 21(1), 2001, pp. 29-35
53. Small, G
    Meeting the challenges of vascular dementia - Introduction
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    G. Small, "Meeting the challenges of vascular dementia - Introduction", INT J CL PR, 2001, pp. 1-4
54. Erkinjuntti, T
    Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    T. Erkinjuntti, "Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD", INT J CL PR, 2001, pp. 14-23
55. Maelicke, A
    The pharmacological rationale for treating vascular dementia with galantamine (Reminyl(Tau Mu))
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    A. Maelicke, "The pharmacological rationale for treating vascular dementia with galantamine (Reminyl(Tau Mu))", INT J CL PR, 2001, pp. 24-28
56. Taylor, S; Pereira, AS
    Antiretroviral drug concentrations in semen of HIV-1 infected men
    SEXUALLY TRANSMITTED INFECTIONS
    
    S. Taylor e A.S. Pereira, "Antiretroviral drug concentrations in semen of HIV-1 infected men", SEX TRANS I, 77(1), 2001, pp. 4-11
57. Zumkeller, W; Westphal, M
    The IGF/IGFBP system in CNS malignancy
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    
    W. Zumkeller e M. Westphal, "The IGF/IGFBP system in CNS malignancy", J CL PATH-M, 54(4), 2001, pp. 227-229
58. Foudraine, NA; Jurriaans, S; Weverling, GJ; Burger, DM; Hoetelmans, RMW; Roos, MTL; Maas, J; Miedema, F; Reiss, P; Portegies, P; de Wolf, F; Lange, JMA
    Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial
    ANTIVIRAL THERAPY
    
    N.A. Foudraine et al., "Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial", ANTIVIR TH, 6(1), 2001, pp. 55-62
59. Damberg, M; Garpenstrand, H; Hallman, J; Oreland, L
    Genetic mechanisms of behavior - Don't forget about the transcription factors
    MOLECULAR PSYCHIATRY
    
    M. Damberg et al., "Genetic mechanisms of behavior - Don't forget about the transcription factors", MOL PSYCHI, 6(5), 2001, pp. 503-510
60. Rothermundt, M; Missler, U; Arolt, V; Peters, M; Leadbeater, J; Wiesmann, M; Rudolf, S; Wandinger, KP; Kirchner, H
    Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology
    MOLECULAR PSYCHIATRY
    
    M. Rothermundt et al., "Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology", MOL PSYCHI, 6(4), 2001, pp. 445-449
61. Abbar, M; Courtet, P; Bellivier, F; Leboyer, H; Boulenger, JP; Castelhau, D; Ferreira, M; Lambercy, C; Mouthon, D; Paoloni-Giacobino, A; Vessaz, M; Malafosse, A; Buresi, C
    Suicide attempts and the tryptophan hydroxylase gene
    MOLECULAR PSYCHIATRY
    
    M. Abbar et al., "Suicide attempts and the tryptophan hydroxylase gene", MOL PSYCHI, 6(3), 2001, pp. 268-273
62. Courtet, P; Baud, P; Abbar, M; Boulenger, JP; Castelnau, D; Mouthon, D; Malafosse, A; Buresi, C
    Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene
    MOLECULAR PSYCHIATRY
    
    P. Courtet et al., "Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene", MOL PSYCHI, 6(3), 2001, pp. 338-341
63. Herken, H; Uz, E; Ozyurt, H; Sogut, S; Virit, O; Akyol, O
    Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation ape increased in different forms of schizophrenia
    MOLECULAR PSYCHIATRY
    
    H. Herken et al., "Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation ape increased in different forms of schizophrenia", MOL PSYCHI, 6(1), 2001, pp. 66-73
64. Brouwers, P; van Engelen, M; Lalonde, F; Perez, L; de Haan, E; Wolters, P; Martin, A
    Abnormally increased semantic priming in children with symptomatic HIV-1 disease: Evidence for impaired development of semantics?
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    
    P. Brouwers et al., "Abnormally increased semantic priming in children with symptomatic HIV-1 disease: Evidence for impaired development of semantics?", J INT NEURO, 7(4), 2001, pp. 491-501
65. Koskiniemi, M; Rantalaiho, T; Piiparinen, H; von Bonsdorff, CH; Farkkila, M; Jarvinen, A; Kinnunen, E; Koskiniemi, S; Mannonen, L; Muttilainen, M; Linnavuori, K; Porras, J; Puolakkainen, M; Raiha, K; Salonen, EM; Ukkonen, P; Vaheri, A; Valtonen, V
    Infections of the central nervous system of suspected viral origin: A collaborative study from Finland
    JOURNAL OF NEUROVIROLOGY
    
    M. Koskiniemi et al., "Infections of the central nervous system of suspected viral origin: A collaborative study from Finland", J NEUROVIRO, 7(5), 2001, pp. 400-408
66. Jensen, PN; Major, EO
    A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region
    JOURNAL OF NEUROVIROLOGY
    
    P.N. Jensen e E.O. Major, "A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region", J NEUROVIRO, 7(4), 2001, pp. 280-287
67. Weber, T; Weber, F; Petry, H; Luke, W
    Immune response in progressive multifocal leukoencephalopathy: An overview
    JOURNAL OF NEUROVIROLOGY
    
    T. Weber et al., "Immune response in progressive multifocal leukoencephalopathy: An overview", J NEUROVIRO, 7(4), 2001, pp. 311-317
68. Antinori, A; Ammassari, A; Giancola, ML; Cingolani, A; Grisetti, S; Murri, R; Alba, L; Ciancio, B; Soldani, F; Larussa, D; Ippolito, G; De Luca, A
    Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era
    JOURNAL OF NEUROVIROLOGY
    
    A. Antinori et al., "Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era", J NEUROVIRO, 7(4), 2001, pp. 323-328
69. Geschwind, MD; Skolasky, RI; Royal, WS; McArthur, JC
    The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS
    JOURNAL OF NEUROVIROLOGY
    
    M.D. Geschwind et al., "The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS", J NEUROVIRO, 7(4), 2001, pp. 353-357
70. Cinque, P; Pierotti, C; Vigano, MG; Bestetti, A; Fausti, C; Bertelli, D; Lazzarin, A
    The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy
    JOURNAL OF NEUROVIROLOGY
    
    P. Cinque et al., "The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy", J NEUROVIRO, 7(4), 2001, pp. 358-363
71. De Luca, A; Giancola, ML; Ammassari, A; Grisetti, S; Cingolani, A; Larussa, D; Alba, L; Murri, R; Ippolito, G; Cauda, R; Monforte, AD; Antinori, A
    Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study
    JOURNAL OF NEUROVIROLOGY
    
    A. De Luca et al., "Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study", J NEUROVIRO, 7(4), 2001, pp. 364-368
72. Yiannoutsos, CT; De Luca, A
    Designs for clinical trials to test the efficacy of therapeutics in progressive multifocal leukoencephalopathy
    JOURNAL OF NEUROVIROLOGY
    
    C.T. Yiannoutsos e A. De Luca, "Designs for clinical trials to test the efficacy of therapeutics in progressive multifocal leukoencephalopathy", J NEUROVIRO, 7(4), 2001, pp. 369-374
73. Gasnault, J; Kousignian, P; Kahraman, M; Rahoiljaon, J; Matheron, S; Delfraissy, JF; Taoufik, Y
    Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: Amonocenter observational study with clinical and JC virus load monitoring
    JOURNAL OF NEUROVIROLOGY
    
    J. Gasnault et al., "Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: Amonocenter observational study with clinical and JC virus load monitoring", J NEUROVIRO, 7(4), 2001, pp. 375-381
74. Ross, HL; Gartner, S; McArthur, JC; Corboy, JR; McAllister, JJ; Millhouse, S; Wigdahl, B
    HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity
    JOURNAL OF NEUROVIROLOGY
    
    H.L. Ross et al., "HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity", J NEUROVIRO, 7(3), 2001, pp. 235-249
75. Stins, MF; Shen, Y; Huang, SH; Gilles, F; Kalra, VK; Kim, KS
    Gp120 activates children's brain endothelial cells via CD4
    JOURNAL OF NEUROVIROLOGY
    
    M.F. Stins et al., "Gp120 activates children's brain endothelial cells via CD4", J NEUROVIRO, 7(2), 2001, pp. 125-134
76. Shieh, TM; Carter, DL; Blosser, RL; Mankowski, JL; Zink, MC; Clements, JE
    Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus
    JOURNAL OF NEUROVIROLOGY
    
    T.M. Shieh et al., "Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus", J NEUROVIRO, 7(1), 2001, pp. 11-24
77. Ferrante, P; Mediati, M; Caldarelli-Stefano, R; Losciale, L; Mancuso, R; Cagni, AE; Maserati, R
    Increased frequency of JC virus type 2 and of dual infection with JC virustype 1 and 2 in Italian progressive multifocal leukoencephalopathy patients
    JOURNAL OF NEUROVIROLOGY
    
    P. Ferrante et al., "Increased frequency of JC virus type 2 and of dual infection with JC virustype 1 and 2 in Italian progressive multifocal leukoencephalopathy patients", J NEUROVIRO, 7(1), 2001, pp. 35-42
78. Spigset, O; Hagg, S
    Therapeutic approaches to bulimia nervosa
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    O. Spigset e S. Hagg, "Therapeutic approaches to bulimia nervosa", EXPERT OP T, 11(3), 2001, pp. 463-477
79. Shelton, RC
    Antidepressant therapy: new targets for drug development
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    R.C. Shelton, "Antidepressant therapy: new targets for drug development", EXPERT OP T, 11(11), 2001, pp. 1693-1711
80. Satoh, JI; Kuroda, Y
    Alpha-synuclein expression is up-regulated in NTera2 cells during neuronaldifferentiation but unaffected by exposure to cytokines and neurotrophic factors
    PARKINSONISM & RELATED DISORDERS
    
    J.I. Satoh e Y. Kuroda, "Alpha-synuclein expression is up-regulated in NTera2 cells during neuronaldifferentiation but unaffected by exposure to cytokines and neurotrophic factors", PARKINS R D, 8(1), 2001, pp. 7-17
81. Holmberg, B; Johnels, B; Ingvarsson, P; Eriksson, B; Rosengren, L
    CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes
    PARKINSONISM & RELATED DISORDERS
    
    B. Holmberg et al., "CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes", PARKINS R D, 8(1), 2001, pp. 23-31
82. Egg, R; Reindl, M; Deisenhammer, F; Linington, C; Berger, T
    Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis
    MULTIPLE SCLEROSIS
    
    R. Egg et al., "Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis", MULT SCLER, 7(5), 2001, pp. 285-289
83. Drulovic, J; Dujmovic, I; Mesaros, S; Samardzic, T; Maksimovic, D; Stojsavljevic, N; Levic, Z; Stojkovic, MM
    Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity
    MULTIPLE SCLEROSIS
    
    J. Drulovic et al., "Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity", MULT SCLER, 7(1), 2001, pp. 19-22
84. Richert, ND; Ostuni, JL; Bash, CN; Leist, TP; McFarland, HF; Frank, JA
    Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis
    MULTIPLE SCLEROSIS
    
    N.D. Richert et al., "Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis", MULT SCLER, 7(1), 2001, pp. 49-58
85. Jensen, J; Krakauer, M; Sellebjerg, F
    Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis
    EUROPEAN JOURNAL OF NEUROLOGY
    
    J. Jensen et al., "Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis", EUR J NEUR, 8(4), 2001, pp. 321-328
86. Vila, M; Jackson-Lewis, V; Guegan, C; Wu, DC; Teismann, P; Choi, DK; Tieu, K; Przedborski, S
    The role of glial cells in Parkinson's disease
    CURRENT OPINION IN NEUROLOGY
    
    M. Vila et al., "The role of glial cells in Parkinson's disease", CURR OP NEU, 14(4), 2001, pp. 483-489
87. Lucchinetti, C; Bruck, W; Noseworthy, J
    Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment
    CURRENT OPINION IN NEUROLOGY
    
    C. Lucchinetti et al., "Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment", CURR OP NEU, 14(3), 2001, pp. 259-269
88. Hohlfeld, R; Wekerle, H
    Immunological update on multiple sclerosis
    CURRENT OPINION IN NEUROLOGY
    
    R. Hohlfeld e H. Wekerle, "Immunological update on multiple sclerosis", CURR OP NEU, 14(3), 2001, pp. 299-304
89. Hinson, VK; Tyor, WR
    Update on viral encephalitis
    CURRENT OPINION IN NEUROLOGY
    
    V.K. Hinson e W.R. Tyor, "Update on viral encephalitis", CURR OP NEU, 14(3), 2001, pp. 369-374
90. Nagai, M; Jacobson, S
    Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy
    CURRENT OPINION IN NEUROLOGY
    
    M. Nagai e S. Jacobson, "Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy", CURR OP NEU, 14(3), 2001, pp. 381-386
91. Bjarnadottir, M; Nilsson, C; Lindstrom, V; Westman, A; Davidsson, P; Thormodsson, F; Blondal, H; Gudmundsson, G; Grubb, A
    The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    
    M. Bjarnadottir et al., "The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids", AMYLOID, 8(1), 2001, pp. 1-10
92. Takasaki, J; Ogawa, Y
    Anti-interleukin-8 autoantibody in the tracheobronchial aspirate of infants with chronic lung disease
    PEDIATRICS INTERNATIONAL
    
    J. Takasaki e Y. Ogawa, "Anti-interleukin-8 autoantibody in the tracheobronchial aspirate of infants with chronic lung disease", PEDIATR INT, 43(1), 2001, pp. 48-52
93. Jang, JY; Suh, CM; Lee, CS
    Analysis of design parameters for shunt valve and anti-siphon device used to treat patients with hydrocephalus
    KSME INTERNATIONAL JOURNAL
    
    J.Y. Jang et al., "Analysis of design parameters for shunt valve and anti-siphon device used to treat patients with hydrocephalus", KSME INT J, 15(7), 2001, pp. 1061-1071
94. Schwaiger, M; Peter, O; Cassinotti, P
    Routine diagnosis of Borrelia burgdorferi (sensu lato) infections using a real-time PCR assay
    CLINICAL MICROBIOLOGY AND INFECTION
    
    M. Schwaiger et al., "Routine diagnosis of Borrelia burgdorferi (sensu lato) infections using a real-time PCR assay", CL MICRO IN, 7(9), 2001, pp. 461-469
95. Kupferschmidt, O; Kruger, D; Held, TK; Ellerbrok, H; Siegert, W; Janitschke, K
    Quantitative detection of Toxoplasma gondii DNA in human body fluids by TaqMan polymerase chain reaction
    CLINICAL MICROBIOLOGY AND INFECTION
    
    O. Kupferschmidt et al., "Quantitative detection of Toxoplasma gondii DNA in human body fluids by TaqMan polymerase chain reaction", CL MICRO IN, 7(3), 2001, pp. 120-124
96. Diksic, M
    Labelled alpha-methyl-L-tryptophan as a tracer for the study of the brain serotonergic system
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    
    M. Diksic, "Labelled alpha-methyl-L-tryptophan as a tracer for the study of the brain serotonergic system", J PSYCH NEU, 26(4), 2001, pp. 293-303
97. Fiszer, U
    Does Parkinson's disease have an immunological basis? The evidence and itstherapeutic implications
    BIODRUGS
    
    U. Fiszer, "Does Parkinson's disease have an immunological basis? The evidence and itstherapeutic implications", BIODRUGS, 15(6), 2001, pp. 351-355
98. Ravussin, P; Wilder-Smith, O
    General anaesthesia for supratentorial neurosurgery
    CNS DRUGS
    
    P. Ravussin e O. Wilder-Smith, "General anaesthesia for supratentorial neurosurgery", CNS DRUGS, 15(7), 2001, pp. 527-535
99. Zisapel, N
    Circadian rhythm sleep disorders - Pathophysiology and potential approaches to management
    CNS DRUGS
    
    N. Zisapel, "Circadian rhythm sleep disorders - Pathophysiology and potential approaches to management", CNS DRUGS, 15(4), 2001, pp. 311-328
100. Giacobini, E
     Do cholinesterase inhibitors have disease-modifying effects in Alzheimer'sdisease?
     CNS DRUGS
     
     E. Giacobini, "Do cholinesterase inhibitors have disease-modifying effects in Alzheimer'sdisease?", CNS DRUGS, 15(2), 2001, pp. 85-91